A Phase I trial of the novel proteasome inhibitor PS341 in advanced solid tumor malignancies

Authors
Category Primary study
JournalCLINICAL CANCER RESEARCH
Year 2002
This article has no abstract
Epistemonikos ID: fa72aa6643f0b6a46e78e00deabda1296306e0dd
First added on: Nov 13, 2025